Trials / Unknown
UnknownNCT02822066
Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and Pancreas
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- First Affiliated Hospital of Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The pupose of this study is to evaluate the safety and efficacy of irreversible electroporation (IRE) for refractory neoplasms in liver and pancreas, the investigators used preoperative and postoperative US/CEUS/CT/MRI to assess lesions, and laboratory tests including the tumor markers to evaluate the general condition of patients. Intraoperative US/CEUS/CT would be applied to monitor ablation lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Electroporation | Effectivity and safety of irreversible electroporation for refractory neoplasms in liver and pancreas |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2018-06-01
- Completion
- 2018-06-01
- First posted
- 2016-07-04
- Last updated
- 2016-07-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02822066. Inclusion in this directory is not an endorsement.